Tyra Biosciences Inc (TYRA)

Apr 29, 2026

TYRA SEC FilingsTyra Biosciences, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 29, 2026

Apr 29, 2026

Tyra Biosciences faces earnings test ahead of key trial data By Investing.com - Investing.com Canada

Apr 29, 2026

Apr 29, 2026

Tyra Biosciences faces earnings test ahead of key trial data - Investing.com UK

Apr 29, 2026

Apr 27, 2026

Tyra Biosciences, Inc. (NASDAQ:TYRA) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Apr 27, 2026

Apr 26, 2026

Guggenheim initiates coverage of Tyra Biosciences (TYRA) with buy recommendation - MSN

Apr 26, 2026

Apr 26, 2026

Does Tyra Biosciences (TYRA) Board Refresh and Dabogratinib Spotlight Reframe Its Pipeline Credibility? - Sahm

Apr 26, 2026

Apr 25, 2026

Guggenheim Securities Issues Buy Rating for Tyra Biosciences - HarianBasis.co

Apr 25, 2026

Apr 24, 2026

Canaan reports 750,000 shares in Tyra Biosciences (NASDAQ: TYRA) - Stock Titan

Apr 24, 2026

Apr 24, 2026

Guggenheim Starts Tyra Biosciences, Inc. (TYRA) at Buy on Strength of Lead Drug Dabogratinib - Yahoo Finance

Apr 24, 2026

Apr 23, 2026

Understanding the Setup: (TYRA) and Scalable Risk - Stock Traders Daily

Apr 23, 2026

Apr 23, 2026

Top 10 AI-Powered Biotech Stocks to Buy Right Now - Insider Monkey

Apr 23, 2026

Apr 22, 2026

Tyra Biosciences (TYRA) Stock: Entry Strategy Overview | Q4 2025: EPS Misses EstimatesCommunity Buy Signals - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 20, 2026

44,400 Tyra Biosciences (TYRA) stock options granted to director Dable - Stock Titan

Apr 20, 2026

Apr 20, 2026

Tyra Biosciences (TYRA) director Dable Habib J files Form 3 showing no share ownership - Stock Titan

Apr 20, 2026

Apr 20, 2026

William Blair Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating - 富途牛牛

Apr 20, 2026

Apr 20, 2026

Tyra Biosciences Announces Appointment of Habib Dable to its Board of Directors - marketscreener.com

Apr 20, 2026

Apr 18, 2026

Tyra Biosciences adds Habib Dable to board of directors By Investing.com - Investing.com India

Apr 18, 2026

Apr 17, 2026

Yuliya Rueb Net Worth (2026) - GuruFocus

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences, Inc. ($TYRA) CEO 2025 Pay Revealed - Quiver Quantitative

Apr 17, 2026

Apr 17, 2026

Cantor Fitzgerald reiterates Tyra Biosciences stock rating By Investing.com - Investing.com South Africa

Apr 17, 2026

Apr 17, 2026

Cantor Fitzgerald reiterates Tyra Biosciences stock rating - Investing.com

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences appoints Habib J. Dable to board of directors By Investing.com - Investing.com Australia

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences appoints Habib J. Dable to board of directors - Investing.com

Apr 17, 2026

Apr 17, 2026

Tyra Bioscience Expands Board, Appoints New Independent Director - TipRanks

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences adds Habib Dable to board of directors - Investing.com

Apr 17, 2026

Apr 17, 2026

[ARS] Tyra Biosciences, Inc. SEC Filing - Stock Titan

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences (TYRA) details 2026 virtual meeting, director votes and auditor - Stock Titan

Apr 17, 2026

Apr 17, 2026

Ty appoints Habib J. Dable to Board as Class II director - TradingView

Apr 17, 2026

Apr 17, 2026

Habib Dable joins Tyra Biosciences (NASDAQ: TYRA) board as Class II director - Stock Titan

Apr 17, 2026

Apr 17, 2026

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unveiling a 45.89% Potential Upside in Biotech Innovation - DirectorsTalk Interviews

Apr 17, 2026

Apr 16, 2026

Tyra Biosciences Advances Dabogratinib Trial in Niche Urothelial Cancer: What Investors Should Watch - TipRanks

Apr 16, 2026

Apr 16, 2026

CCORF Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛

Apr 16, 2026

Apr 16, 2026

Tyra Biosciences (NASDAQ:TYRA) Stock Rating Upgraded by Guggenheim - MarketBeat

Apr 16, 2026

Apr 15, 2026

TYRA Initiates Coverage On by Guggenheim -- Price Target Announced at $54.00 - GuruFocus

Apr 15, 2026

Apr 15, 2026

This Tyra Biosciences Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Apr 15, 2026

Apr 15, 2026

Guggenheim Maintains TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Maintains Target Price $54 - 富途牛牛

Apr 15, 2026

Apr 15, 2026

Guggenheim Initiates Tyra Bioscience at Buy With $54 Price Target - marketscreener.com

Apr 15, 2026

Apr 14, 2026

Guggenheim Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $54 - 富途牛牛

Apr 14, 2026

Apr 13, 2026

TYRA (Nasdaq) Form 144: Director reports two 8,000-share transactions - Stock Titan

Apr 13, 2026

Apr 13, 2026

The Technical Signals Behind (TYRA) That Institutions Follow - Stock Traders Daily

Apr 13, 2026

Apr 12, 2026

Growth Stocks To Watch Today – April 10th - Defense World

Apr 12, 2026

Apr 11, 2026

JPMorgan Chase & Co. Trims Position in Tyra Biosciences, Inc. $TYRA - MarketBeat

Apr 11, 2026

Apr 07, 2026

IPO Launch: Is Tyra Biosciences Incs ROE strong enoughEntry Point & Precise Swing Trade Alerts - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

FMR LLC holds 14.4% of Tyra Biosciences (NASDAQ: TYRA) - Stock Titan

Apr 07, 2026

Apr 07, 2026

Tyra Biosciences (NASDAQ:TYRA) Now Covered by Canaccord Genuity Group - Defense World

Apr 07, 2026

Apr 06, 2026

Canaccord Genuity Group Begins Coverage on Tyra Biosciences (NASDAQ:TYRA) - MarketBeat

Apr 06, 2026

Apr 06, 2026

Canaccord Genuity Initiates Tyra Bioscience at Buy With $50 Price Target - marketscreener.com

Apr 06, 2026

Apr 06, 2026

CCORF Initiates TYRA BIOSCIENCES, INC.(TYRA.US) With Buy Rating, Announces Target Price $50 - 富途牛牛

Apr 06, 2026

Apr 06, 2026

Is Tyra Biosciences (TYRA) Stock a Good Buy in 2026 | Price at $38.93, Down 1.72%Investment Signal Network - Xã Thanh Hà

Apr 06, 2026

Apr 05, 2026

Growth Stocks To Watch Now – April 3rd - Defense World

Apr 05, 2026